GALLERY

Principales Publications Scientifiques depuis 2018

J Psychiatric Research.jpg

Pabst A, Peyroux E, Rolland B, de Timary P, Maurage P
Hostile attributional bias in severe alcohol use disorder

J Psychiatr Res. 2020; 129:176-180.

NBR.jpg

Dondé C, Brunelin J, Mondino M, Cellard C, Rolland B, Haesebaert F.
The effects of acute nicotine administration on cognitive and early sensory processes in schizophrenia: a systematic review

Neurosci Biobehav Rev. 2020; 118:121-133.

Rolland B, Haesebaert F, Zante E, Benyamina A, Haesebaert J, Franck N. 
Global changes and factors of increase in caloric/salty food, screen, and substance use, during the early COVID-19 containment phase in France: a general population online survey

JMIR Public Health Surveill. 2020; doi: 10.2196/19630.

Therapies.gif

Chappuy M, Trojak B, Nubukpo P, Bachellier J, Bendimerad P, Brousse G, Rolland B.
Prolonged-release buprenorphine formulations: perspectives for clinical practice

Therapies. 2020; https://doi.org/10.1016/j.therap.2020.05.007

SiH Logo.jpg

Gelis A, Cervello S, Rey R, Llorca G, Lambert P, Franck N, Dupeyron A, Delpont M, Rolland B.
Peer Role-Play for Training Communication Skills in Medical Students: A Systematic Review.

Simul Healthc. 2020; doi: 10.1097/SIH.0000000000000412

EOP.jpeg

Geoffroy PA, Lejoyeux M, Rolland B.
Management of insomnia in alcohol use disorder.

Expert Opin Pharmacother. 2020; 21(3):297-306. doi: 10.1080/14656566.2019.1705279.

Cover Lancet 2020.jpg

Chappuy M, Boulanger A, Nourredine M, Fourneret P, Rolland B.
Disparate regulatory status of methylphenidate for adults with ADHD across Europe.

Lancet Psychiatry. 2020; 7(1):e1-e2. doi: 10.1016/S2215-0366(19)30482-1.

Progress in Neuropsychopharmacology.jpg

Meyrel M, Rolland B, Geoffroy PA.
Alterations in circadian rhythms following alcohol use: A systematic review.

Prog Neuropsychopharmacol Biol Psychiatry. 2020; 99:109831. doi: 10.1016/j.pnpbp.2019.109831.

Capture d'écran 2019-10-29 20.59.51.png

Rolland B, Simon N, Franchitto N, Aubin HJ.
France Grants an Approval to Baclofen for Alcohol Dependence.

Alcohol Alcohol. 2020; 55(1):44-45. doi: 10.1093/alcalc/agz082.

Capture d'écran 2019-10-29 20.59.51.png

Pignon B, Sescousse G, Amad A, ..., Roelandt JL, Rolland B.
Alcohol Use Disorder Is Differently Associated With Psychotic Symptoms According To Underlying Psychiatric Disorders: A General Population Study.

Alcohol Alcohol. 2020; 55(1):112-120. doi: 10.1093/alcalc/agz077

cover-translational-psychiatry.jpg

Li Y, Wang Z, Boileau I, Dreher JC, ..., van Timmeren T, Sescousse G
Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study.

Transl Psychiatry. 2019; 9(1):186. doi: 10.1038/s41398-019-0520-8

EODD.png

Vorspan F, Hjelmström P, Simon N, ..., Kosim M, Rolland B
What place for prolonged-release buprenorphine depot formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine.

Expert Opin Drug Deliv. 2019. 16(9):907-914. doi: 10.1080/17425247.2019.1649252.

Scientific-Reports-nature.jpg

Carton L, Auger F, Kyheng M, ..., Bordet R, Rolland B
Dose-dependent metabolite changes after ethanol intoxication in rat prefrontal cortex using in vivo magnetic resonance spectroscopy.

Sci Rep. 2019; 9(1):10682. doi: 10.1038/s41598-019-47187-4.

Capture d'écran 2019-06-23 20.18.21.png

De Ternay J, Naassila M, Nourredine M, Louvet A, Bailly F, Sescousse G, Maurage P, Cottencin O, Carrieri PM, Rolland B.
Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain.

Front Pharmacol. 2019; 10:627. doi: 10.3389/fphar.2019.00627.

couverture-neuroImage

Mas-Herrero E, Sescousse G, Cools R, Marco-Pallarés J.
The contribution of striatal pseudo-reward prediction errors to value-based decision-making. 
Neuroimage. 2019; 193:67-74.doi: 10.1016/j.neuroimage.2019.02.052.

couverture-journal-thérapie.PNG

Lenglard F, Berger-Vergiat A, Ragonnet D, Duvernay N, Lack P, Poulet E, Zoulim F, Chappuy M.

Retour d'expérience de deux CSAPA et enquête nationale sur la naloxone intranasale (Nalscue®) dans la prévention des overdoses aux opioïdes

Thérapie. 2019; 74(4):477-486.

couverture-Lancet-psychiatrie.jpg

Agabio R, Sinclair JM, Addolorato G, ..., Rolland B, Stafford A, Thompson A, van den Brink W, de Beaurepaire R, Leggio L. 
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. 
Lancet Psychiatry. 2018; 5(12):957-960.

psychiatry_flyer_cropmarks.jpg

Simon N, Moirand R, Dematteis M, Bordet R, Deplanque D, Rolland B.
Full-Profile Pharmacokinetic Study of High Dose Baclofen in Subjects With Alcohol Use Disorder.

Front Psychiatry. 2018; 9:385.

© 2023 Service Universitaire d'Addictologie de Lyon (SUAL) - template : Wix.com - images : services communication du CH le Vinatier et des HCL.